Literature DB >> 1519192

Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction.

F W Dekker1, A C Schrier, P J Sterk, J H Dijkman.   

Abstract

BACKGROUND: Assessing the reversibility of airflow obstruction by peak expiratory (PEF) measurements would be practicable in general practice, but its usefulness has not been investigated.
METHODS: PEF measurements were performed (miniWright peak flow meter) in 73 general practice patients (aged 40 to 84) with a history of asthma or chronic obstructive lung disease before and after 400 micrograms inhaled sulbutamol. The change in PEF was compared with the change in forced expiratory volume in one second (FEV1). Reversible airflow obstruction was analysed in two ways according to previous criteria. When defined as a 9% or greater increase in FEV1 expressed as a percentage of predicted values reversibility was observed in 42% of patients. Relative operating characteristic analysis showed that an absolute improvement in PEF of 60 l/min or more gave optimal discrimination between patients with reversible and irreversible airflow obstruction (the sensitivity and specificity of an increase of 60 l/min in detecting a 9% or more increase in FEV1 as a percentage of predicted values were 68% and 93% respectively, with a positive predictive value of 87%). When defined as an increase of 190 ml or more in FEV1, reversible airflow obstruction was observed in 53% of patients. Again an absolute improvement in PEF of 60 l/min or more gave optimal discrimination between patients with reversible and irreversible airflow obstruction (sensitivity 56%, specificity 94%, and positive predictive value 92%).
CONCLUSION: Absolute changes in PEF can be used as a simple technique to diagnose reversible airflow obstruction in patients from general practice.

Entities:  

Mesh:

Year:  1992        PMID: 1519192      PMCID: PMC1021004          DOI: 10.1136/thx.47.3.162

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  21 in total

1.  COPD: a disease of reversible air-flow obstruction.

Authors:  N J Gross
Journal:  Am Rev Respir Dis       Date:  1986-05

2.  The MRC-ECCS questionnaire on respiratory symptoms (use in epidemiology).

Authors:  R van der Lende; N G Orie
Journal:  Scand J Respir Dis       Date:  1972

3.  The diagnosis and treatment of adults with obstructive airways disease in general practice.

Authors:  A G Wardman; V Binns; A D Clayden; N J Cooke
Journal:  Br J Dis Chest       Date:  1986-01

4.  Short term variability in FEV1: relation to pretest activity, level of FEV1, and smoking habits.

Authors:  P M Tweeddale; S Merchant; M Leslie; F Alexander; G J McHardy
Journal:  Thorax       Date:  1984-12       Impact factor: 9.139

5.  The quality of care of asthma in general practice--a challenge for the future.

Authors:  I Gregg
Journal:  Fam Pract       Date:  1985-06       Impact factor: 2.267

6.  Improvement of pressurised aerosol deposition with Nebuhaler spacer device.

Authors:  S P Newman; A B Millar; T R Lennard-Jones; F Morén; S W Clarke
Journal:  Thorax       Date:  1984-12       Impact factor: 9.139

7.  The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables.

Authors:  O Eliasson; A C Degraff
Journal:  Am Rev Respir Dis       Date:  1985-10

8.  Underdiagnosis of asthma in the elderly.

Authors:  D K Banerjee; G S Lee; S K Malik; S Daly
Journal:  Br J Dis Chest       Date:  1987-01

9.  Bronchodilator response in chronic obstructive pulmonary disease.

Authors:  N R Anthonisen; E C Wright
Journal:  Am Rev Respir Dis       Date:  1986-05

10.  Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life.

Authors:  G H Guyatt; M Townsend; S O Pugsley; J L Keller; H D Short; D W Taylor; M T Newhouse
Journal:  Am Rev Respir Dis       Date:  1987-05
View more
  10 in total

1.  Testing bronchial hyper-responsiveness: provocation or peak expiratory flow variability?

Authors:  J J den Otter; G M Reijnen; W J van den Bosch; C P van Schayck; J Molema; C van Weel
Journal:  Br J Gen Pract       Date:  1997-08       Impact factor: 5.386

2.  Overview of nebuliser treatment.

Authors:  M F Muers
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

3.  Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations.

Authors:  Ritesh Agarwal; Sahajal Dhooria; Ashutosh Nath Aggarwal; Venkata N Maturu; Inderpaul S Sehgal; Valliappan Muthu; Kuruswamy T Prasad; Lakshmikant B Yenge; Navneet Singh; Digambar Behera; Surinder K Jindal; Dheeraj Gupta; Thanagakunam Balamugesh; Ashish Bhalla; Dhruva Chaudhry; Sunil K Chhabra; Ramesh Chokhani; Vishal Chopra; Devendra S Dadhwal; George D'Souza; Mandeep Garg; Shailendra N Gaur; Bharat Gopal; Aloke G Ghoshal; Randeep Guleria; Krishna B Gupta; Indranil Haldar; Sanjay Jain; Nirmal K Jain; Vikram K Jain; Ashok K Janmeja; Surya Kant; Surender Kashyap; Gopi C Khilnani; Jai Kishan; Raj Kumar; Parvaiz A Koul; Ashok Mahashur; Amit K Mandal; Samir Malhotra; Sabir Mohammed; Prasanta R Mohapatra; Dharmesh Patel; Rajendra Prasad; Pallab Ray; Jai K Samaria; Potsangbam Sarat Singh; Honey Sawhney; Nusrat Shafiq; Navneet Sharma; Updesh Pal S Sidhu; Rupak Singla; Jagdish C Suri; Deepak Talwar; Subhash Varma
Journal:  Lung India       Date:  2015-04

4.  Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis.

Authors:  P R Tirimanna; J J Den Otter; C P Van Schayck; C L Van Herwaarden; H Folgering; C Van Weel
Journal:  Br J Gen Pract       Date:  1996-01       Impact factor: 5.386

5.  Can peak expiratory flow measurements reliably identify the presence of airway obstruction and bronchodilator response as assessed by FEV(1) in primary care patients presenting with a persistent cough?

Authors:  H A Thiadens; G H De Bock; J C Van Houwelingen; F W Dekker; M W De Waal; M P Springer; D S Postma
Journal:  Thorax       Date:  1999-12       Impact factor: 9.139

6.  Factors Contributing to 50-ft Walking Speed and Observed Ethnic Differences in Older Community-Dwelling Mexican Americans and European Americans.

Authors:  Myla U Quiben; Helen P Hazuda
Journal:  Phys Ther       Date:  2015-01-15

7.  Human airway musculature on a chip: an in vitro model of allergic asthmatic bronchoconstriction and bronchodilation.

Authors:  Alexander Peyton Nesmith; Ashutosh Agarwal; Megan Laura McCain; Kevin Kit Parker
Journal:  Lab Chip       Date:  2014-10-21       Impact factor: 6.799

8.  Diagnosis of asthma and chronic obstructive pulmonary disease in general practice.

Authors:  C P Van Schayck
Journal:  Br J Gen Pract       Date:  1996-03       Impact factor: 5.386

9.  Secondary outcomes of a pilot randomized trial of azithromycin treatment for asthma.

Authors:  David L Hahn; Mary Beth Plane; Olaimatu S Mahdi; Gerald I Byrne
Journal:  PLoS Clin Trials       Date:  2006-06-30

10.  Logistic regression model for prediction of airway reversibility using peak expiratory flow.

Authors:  Javad Shakeri; Omalbanin Paknejad; Keivan Gohari Moghadam; Maryam Taherzadeh
Journal:  Tanaffos       Date:  2012
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.